nausea
Instructed in new medication Avapro to manage hypertension. In addition, warned of possible S/E such as fatigue, anxiety, dizziness, headache, chest pain, edema, tachycardia, pharyngitis, rhinitis, sinus abnormality, diarrhea, dyspepsia, abdominal pain, nausea, vomiting, urinary tract infection, musculoskeletal trauma, or pain, upper respiratory tract infection, rash.
Instructed in new medication Bextra to manage osteoarthritis. In addition. warned of possible S/E such as dizziness, headache, cerebrovascular disorder, peripheral edema, hypertension, angina pectoris, arrhythmia, heart failure, aneurysm, sinusitis, abdominal fullness, abdominal pain, diarrhea, dyspepsia, flatulence, nausea, renal impairment, thrombocytopenia, leukopenia, anemia, hepatitis, hyperglycemia, hypercholesterolemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypocalcemia, hypokalemia, increased or decreased weight, back pain, myalgia, upper respiratory tract infection, bronchospasm, rash, flu-like syndrome, accidental injury.
Instructed in new medication Calcium and in S/E such as headache, weakness, dizziness, paresthesia, chest pressure, facial flushing, edema of feet, eye pain, nasal congestion, transient nausea, unusual taste, diarrhea, anorexia, vomiting, epigastric discomfort, abdominal pain, increased urinary frequency, nocturia, shortness of breath, rash, pruritus of ear lobes, inflammation at injection site, hypersensitivity reactions (anaphylaxis), chills and tender palms and soles.
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Allopuriniol and in S/E such as drowsiness, fever, headache, paresthesia, peripheral neuropathy, neuritis, hypersensitivity vasculitis, necrotizing angiitis, epistaxis, nausea, vomiting, diarrhea, abdominal pain, gastritis, taste loss (or perversion, dyspepsia), renal failure, uremia, agranulocytosis, anemia, aplastic anemia, thrombocytopenia, leukopenia, leukocytosis, eosinophilia, hepatitis, hepatic necrosis, hepatomegaly, cholestatic jaundice, arthralgia, myopathy, rash, exfoliative, urticarial, and purpuric lesions, erythema multiforme, severe furunculosis of nose, ichthyosis, alopecia, toxic epidermal necrolysis, ecchymoses, chills.
Instructed in new medication Cozaar and in S/E such as dizziness, asthenia, fatigue, headache, insomnia, edema, chest pain, nasal congestion, sinusitis, pharyngitis, sinus disorder, abdominal pain, nausea, diarrhea, dyspepsia, muscle cramps, myalgia, back or leg pain, cough, upper respiratory infection, angioedema, asthenia, fatigue, fever, hypesthesia, chest pain, hypotension, orthostatic hypotension, sinusitis, cataract, diarrhea, dyspepsia, gastritis, urinary tract infection, anemia, hyperkalemia, hypoglycemia, weight gain, back pain, leg or knee pain, muscle weakness, cough, bronchitis, cellulites and others.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Advair diskus to manage asthma. In addition, warned of possible S/E such as sleep disorders, tremor, hypnagogic effects, compressed nerve syndromes, headache, pain, palpitations, pharyngitis, sinusitis, hoarseness (or dysphonia), rhinorrhea, rhinitis, sneezing, nasal irritation, blood in nasal mucosa, keratitis, conjunctivitis, eye redness, viral eye infections, congestion, nausea, vomiting, abdominal pain and discomfort, diarrhea, gastroenteritis, oral discomfort and pain, constipation, oral ulcerations, oral erythema and rashes, oral candidiasis, appendicitis, dental discomfort and pain, unusual taste, muscular pain, arthralgia, articular rheumatism, muscle stiffness, tightness, rigidity, bone and cartilage disorders, upper respiratory tract infection, upper respiratory tract inflammation, lower respiratory tract viral infection, bronchitis, cough, pneumonia, urticaria, flakiness, disorders of sweat and sebum, sweating, hives, viral infections, chest symptoms, fluid retention, bacterial infections, allergic reactions.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin rash, blurred vision, confusion, anxiety, redness, etc.